Volume 16, Number 2—February 2010
Research
Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007
Eleni Galanis
, Laura MacDougall, Sarah Kidd, Mohammad Morshed, and the British Columbia Cryptococcus gattii Working Group
, Laura MacDougall, Sarah Kidd, Mohammad Morshed, and the British Columbia Cryptococcus gattii Working Group
Table 3
ICD-10 codes for cryptococcosis hospitalizations, British Columbia, Canada, 1999–2006 (N = 322)*
| Condition (ICD-10 code) | Cryptococcosis without HIV/AIDS, no. (%)† | Cryptococcosis with HIV/AIDS, no. (%)† | p value |
|---|---|---|---|
| Pulmonary cryptococcosis (B45.0) | 130 (56.5) | 13 (6.7) | <0.001 |
| Cerebral cryptococcosis (B45.1) | 63 (27.4) | 150 (77.7) | <0.001 |
| Cutaneous cryptococcosis (B45.2) | 7 (3.0) | 1 (0.5) | 0.044 |
| Osseous cryptococcosis (B45.3) | 1 (0.4) | 0 | ND |
| Disseminated cryptococcosis (B45.7) | 5 (2.2) | 22 (11.4) | <0.001 |
| Other forms of cryptococcosis (B45.8) | 11 (4.8) | 6 (3.1) | 0.289 |
| Cryptococcus, unspecified (B45.9) | 13 (5.7) | 12 (6.2) | 0.834 |
| Missing ICD-10 code |
36 |
74 |
|
| Total | 266 | 267 |
*ICD-10, International Classification of Diseases, tenth revision; ND, not determined.
†Total hospitalizations minus hospitalizations for which ICD code is missing.
1Members involved in this study were Patrick Doyle, John Galbraith, Linda Hoang, Pamela Kibsey, Min-Kuang Lee, Sultana Mithani, Marc Romney, and Diane Roscoe.
Page created: August 29, 2012
Page updated: August 29, 2012
Page reviewed: August 29, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.